This fund focuses on innovative low-carbon technologies and processes in energy intensive industries, including products substituting carbon intensive ones incl. carbon capture and utilisation, innovative renewable energy generation and storage. It has a special programme for small-scale projects with total capital costs under €7.5 million.
The programme consists of a combination of both open and challenge driven funding. It supports the exploration of bold ideas for radically new technologies and welcomes the high-risk and interdisciplinary cutting-edge science collaborations that underpin technological breakthroughs.
Aimed for international projects that boost rapidly marketable innovative products. Eurostars is an ideal first step enabling SMEs to combine and share expertise beyond national borders. The consortium must have partners based in at least two different Eurostars countries. Funding on average is in the range of 50-75% of project costs.
Copyright © 2024 DON Therapeutics - All Rights Reserved.
DON THERAPEUTICS LTD is not a Registered Investment Advisor, Broker/Dealer, Financial Analyst, Financial Bank, Securities Broker or Financial Planner. The Information on this 1. Company email, 2 Company Site, 3 Company LinkedIn is provided for information purposes only. The Information is not intended to be and does not constitute financial advice or any other advice, is general in nature and not specific to you. Before using the Company’s information to make an investment decision, you should seek the advice of a qualified and registered securities professional and undertake your own due diligence. None of the information on our email, website, or LinkedIn is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. The Company is not responsible for any investment decision made by you. You are responsible for your own investment research and investment decisions.
Powered by DON Therapeutics